[Genetic Counselor]

NIPT is a blood test done on the mother (usually after 10 weeks of gestation) that analyzes cell-free fetal DNA (cffDNA) circulating in maternal blood. It screens for common chromosomal conditions — primarily Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome) and can also screen for sex chromosome variations.

NIPT has a much higher sensitivity and specificity than traditional biochemical screening (double/quad marker tests) for the common trisomies, with detection rates typically above 99% for Trisomy 21.

Who should care:

*Patients with an abnormal double marker, triple marker, or quad screen
*Patients with soft markers on ultrasound
*Advanced maternal age (35+)
*Anyone wanting a highly sensitive screening option, regardless of background risk

NIPT is typically offered from 10 weeks gestation onward. It’s a screening test, not a replacement for diagnostic testing when a definitive answer is required (e.g., before major medical decisions).

A low-risk NIPT result significantly reduces anxiety and often avoids the need for invasive testing. A high-risk NIPT result prompts a diagnostic test (amniocentesis or CVS) for confirmation before any clinical decision is made.

Limitations:

NIPT is a screening test, not diagnostic — a “high risk” result must be confirmed with amniocentesis or CVS.
False positives and false negatives, while rare, do occur.
It does not screen for all genetic or structural conditions — a normal NIPT does not rule out other issues (e.g., structural anomalies still require ultrasound follow-up).
Placental mosaicism or vanishing twin can occasionally cause discordant results.

[Genetic Counselor]

Soft markers are minor variations seen on a fetal ultrasound that are not structural abnormalities but are statistically associated with a slightly higher chance of chromosomal conditions (such as Down syndrome/Trisomy 21, Trisomy 18, or Trisomy 13). They are not defects — they are subtle sonographic findings that can occur in completely healthy fetuses as well.

Common soft markers include:

Nuchal fold thickening
Echogenic intracardiac focus (EIF)
Echogenic bowel
Mild pyelectasis (renal pelvis dilation)
Shortened femur or humerus length
Choroid plexus cysts
Absent or hypoplastic nasal bone
Absent or hypoplastic retronasal triangle (discussed below)

Soft markers shift risk, they don’t confirm or rule out a condition on their own. A single isolated soft marker in a low-risk pregnancy is usually not significant. Multiple markers, or a marker combined with an already elevated risk (from maternal age, NIPT, or biochemical screening), carries more weight.

Soft marker findings are used to refine existing risk assessments. They often prompt a conversation about further testing (NIPT, amniocentesis) depending on background risk. It usually leads to a follow-up scan, a genetic counseling discussion, and sometimes a recommendation for NIPT or diagnostic testing.

Limitations: Soft markers have low specificity, many normal fetuses show one marker. Their significance depends heavily on gestational age, whether it’s isolated or multiple, and the mother’s baseline risk. They are not diagnostic; they are probabilistic.

[Genetic Counselor]

At 17 weeks, a non-visualized retronasal triangle can imply one of the following, and distinguishing between them requires careful evaluation:

Technical/positional limitation: fetal position, maternal body habitus, or scanning angle can prevent clear visualization even when anatomy is normal. This is the most common reason and is not itself concerning.
Possible cleft lip/palate: since the retronasal triangle view is used specifically to screen for facial clefts, non-visualization warrants a dedicated, detailed facial and palate assessment.
Association with chromosomal anomalies: in some studies, an absent retronasal triangle has been linked to a higher likelihood of Trisomy 21 and other aneuploidies, particularly when seen alongside other soft or hard markers.

What it implies for the fetus:

It does not, by itself, confirm a diagnosis of cleft lip/palate or a chromosomal condition.
It is a prompt for further evaluation, not a conclusion.

This is a good example of why isolated findings should never be interpreted in isolation from the fetus’s full scan and screening history. The clinical significance depends entirely on:

Whether it’s an isolated finding or accompanied by other markers/structural findings
The mother’s background risk (age, prior screening results)
Whether a repeat scan can achieve visualization

Limitations:

*Non-visualization at 17 weeks is later than the ideal window (11–14 weeks) for this specific marker, so its predictive value at this gestation is less standardized in literature compared to first-trimester assessment.
*A single research-based association does not equal individual diagnostic certainty — this is why follow-up imaging and, where indicated, genetic counseling matter more than the marker in isolation.

During first-trimester screening, the fetal nasal bone is assessed as a “soft marker” — a physical feature that, when absent or underdeveloped (hypoplastic), is statistically associated with a higher chance of certain chromosomal conditions, most notably Trisomy 21 (Down syndrome). It’s also occasionally associated with some structural or skeletal conditions, though far less commonly.

A soft marker is not a diagnosis on its own. Many babies with an absent or hypoplastic nasal bone turn out to be chromosomally and structurally completely normal. The finding adjusts a risk estimate usually alongside other markers like NT, blood markers, and maternal age, rather than confirming anything by itself.

Hypoplastic means underdeveloped or smaller than expected for the gestational age. This is different from “absent,” where no nasal bone is visualized at all. Both are grouped together as abnormal findings in many reports, but they’re technically distinct: hypoplastic means the bone is there but under-measured; absent means it isn’t seen.

NT of 2.0mm at 12 weeks 6 days is well within the normal range (the cutoff is typically under 2.5–3.0mm depending on CRL at this gestational age). A normal NT lowers overall concern.
NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA in maternal blood and has very high sensitivity for Trisomy 21, and high sensitivity for Trisomy 18 and 13. A negative NIPT result substantially lowers the likelihood of these conditions, even when an isolated soft marker like nasal bone hypoplasia is present.

It’s worth understanding that NIPT is a screening test, not a diagnostic one: it estimates probability rather than confirming or ruling out a condition with certainty, and it doesn’t screen for every possible genetic or chromosomal condition. But for the specific conditions nasal bone hypoplasia is most associated with, a negative NIPT is meaningfully reassuring.

Get a detailed anomaly/Level II scan with a maternal-fetal medicine (MFM) specialist, who can directly reassess the nasal bone and check for any other associated structural findings.
Discuss the combined picture- NT, NIPT result, and nasal bone finding with a genetic counselor, who can walk you through an individualized, updated risk assessment rather than a general statistic.
Amniocentesis is a diagnostic option that gives a definitive answer, but given if normal NT and negative NIPT, it is not automatically necessary. The decision is a personal one best made after the detailed scan and counseling – not something you need to decide right away out of fear.

[Genetic Counselor]

Not necessarily. If both parents carry a change in gene causing the same genetic condition, each pregnancy has a 25% chance of the child inheriting the genetic change from both parents and being affected, a 50% chance of the child being a carrier like the parents, and a 25% chance of the child not inheriting the changed gene at all. These odds apply to each individual pregnancy.

[Genetic Counselor]

Babies born with Down syndrome usually undergo a few routine checks in the first days and weeks:

*Heart evaluation (echocardiogram)
*Hearing check
*Thyroid function test
*Check for any digestive tract differences
*A blood test to confirm the diagnosis genetically

Many babies have low muscle tone (hypotonia), which can make feeding slower at first. Lactation support and early physiotherapy referrals help significantly here.

Children with Down syndrome benefit from regular, coordinated check-ups rather than one-off treatment:

*Annual thyroid checks
*Regular vision and hearing checks
*Early speech, occupational, and physical therapy
*Monitoring for sleep apnea and, less commonly, celiac disease

Every child with Down syndrome develops differently. Intellectual disability is usually mild to moderate, and with early intervention, many children go on to attend inclusive schools, build strong communication skills, and live independent, fulfilling lives as adults.

[Genetic Counselor]

Non-Invasive Prenatal Testing (NIPT) analyzes small fragments of fetal DNA circulating in the mother’s blood to screen for common chromosomal conditions (such as Down syndrome) starting from around the 10th week of pregnancy. It’s a screening test, not diagnostic – meaning a high-risk result would typically be followed up with a diagnostic test like amniocentesis or CVS (chorionic villus sampling), which directly samples fetal tissue for confirmation.

[Genetic Counselor]

Single-gene testing looks at one specific gene, typically used when there’s a clear clinical suspicion pointing to one condition (e.g., testing the CFTR gene for cystic fibrosis).
Panel testing examines a curated group of genes associated with a related set of conditions (e.g., a hereditary breast and ovarian cancer panel covering BRCA1, BRCA2, and other related genes).
Whole exome sequencing (WES) analyzes the protein-coding regions of nearly all genes, useful when the clinical picture doesn’t point to one specific gene or condition.
Whole genome sequencing (WGS) analyzes the entire genome, including non-coding regions, offering the most comprehensive view, though it’s typically reserved for complex or undiagnosed cases due to cost and data complexity.

[Genetic Counselor]

Genetic tests are broadly categorized based on their purpose:

Diagnostic testing – confirms or rules out a suspected genetic condition in a symptomatic individual.
Carrier screening – determines if a person carries a gene variant for a recessive condition that could be passed to children, even if they show no symptoms themselves.
Predictive or presymptomatic testing – identifies risk for conditions that may develop later in life (e.g., hereditary cancers, neurodegenerative disorders) in individuals with a family history but no current symptoms.
Prenatal testing – performed during pregnancy to assess genetic conditions in the fetus (includes NIPT, CVS, and amniocentesis-based testing).
Newborn screening – tests infants shortly after birth for treatable genetic and metabolic conditions.
Pharmacogenomic testing – evaluates how a person’s genetic makeup affects their response to specific medications, helping guide drug and dosage choices.
Pre-implantation genetic testing (PGT) – used alongside IVF to screen embryos for genetic conditions before implantation.
Somatic/tumor genetic testing – analyzes genetic changes within tumor cells (not inherited) to guide cancer treatment decisions.

[Genetic Counselor]

After sample collection, DNA is extracted and either targeted regions (specific genes) or the entire genome/exome is sequenced. The resulting data is compared against reference genetic databases to identify variants. These variants are then classified into pathogenic, likely pathogenic, benign, likely benign, or of uncertain significance (VUS) — based on established clinical and scientific guidelines. A geneticist or genetic counselor then interprets these findings in the context of the patient’s personal and family history before sharing results.

[Genetic Counselor]

Genetic testing is a medical investigation that analyzes DNA, RNA, chromosomes, or specific proteins to identify changes that may cause, contribute to, or indicate risk for a health condition. Samples are usually collected through blood, saliva, buccal swabs, or in some cases, amniotic fluid or chorionic villus tissue during pregnancy. The DNA is then processed in a laboratory and analyzed using specialized techniques ranging from single-gene analysis to whole genome sequencing.

[Genetic Counselor]

No. Some genetic conditions run in families, but others happen due to a new random change in a gene that neither parent carries. This is why a family with no history of a condition can still have a child affected by one.

[Genetic Counselor]

Carriers are people who have a change in one copy of a gene for a condition, but don’t have the condition themselves. This happens with recessive conditions, where you need a gene change in both copies of a gene (one from each parent) to actually be affected. A carrier has one normal copy and one changed copy: the normal copy is enough to keep them healthy, so they usually show no symptoms and often don’t know they’re a carrier at all.

[Genetic Counselor]

There are several types of genetic tests, each suited to a different need. These include carrier screening (to check if an individual is a carrier for a genetic condition), prenatal testing (testings during pregnancy when the prenatal screenings are indicative of the pregnancy to have a genetic condition), diagnostic testing (to confirm a suspected condition), predictive testing (for future health risks like hereditary cancer), and newborn screening. Your geneticist will recommend the right test based on your specific situation.

[Genetic Counselor]

Yes. Genetic testing is not only for people who are already unwell. It is often recommended for people who are healthy but want to know their risk of being a carrier for a disease and planning a pregnancy, those with a family history of a condition, or those wanting to understand their risk for certain hereditary cancers before any symptoms appear.

[Genetic Counselor]

Genetic counseling is a consultation with a trained specialist who helps understand how a genetic condition may affect those with genetic disease or their family. It covers family history, risk of passing on a condition, and what testing options are available, all explained in plain language so that they can make informed decisions. Anyone considering genetic testing is advised to undergo genetic counseling before and after testing so that they have full support in understanding what the results mean for them and their family.

[Author]

Posts